No over-coagulation occurs if the therapeutic guidelines of a thromboplastin inhibitor are followed
von Thun, W.; Kimmich, F.
Deutsche Medizinische Wochenschrift 110(28-29): 1144
1985
ISSN/ISBN: 0012-0472 PMID: 4006772 Document Number: 266558
Document emailed within 1 workday
Related Documents
Opartkiattikul, N.; Talalak, P. 1987: Thai National Reference Preparation in Blood Coagulation. II. Selection of high sensitivity thromboplastin, calibration against national reference thromboplastin Journal of the Medical Association of Thailand 70(10): 587-591Lämmle, B.; Furlan, M.; Sulzer, I. 1989: Comparison of a sensitive rabbit brain thromboplastin and a human placenta thromboplastin for thromboplastin time determination Schweizerische Medizinische Wochenschrift 119(6): 178-183
Van den Besselaar, A.M.; Ram, I.E.; Alderkamp, G.H.; Bertina, R.M. 1982: The role of factor IX in tissue thromboplastin induced coagulation Thrombosis and Haemostasis 48(1): 54-58
Miyoshi, M.; Miyoshi, Y. 1983: Intraglomerular coagulation with special reference to glomerular tissue thromboplastin Nihon Jinzo Gakkai Shi 25(6): 663-686
Deniz, A.; Mischke, R.; Nolte, I. 1995: Applicability of activated partial thromboplastin time (APTT) as a screening test of milk to medium deficiencies of coagulation factors in cats Deutsche Tierärztliche Wochenschrift 102(5): 206-208
Barthels, M.; Bruhn, H.D.; Duckert, F.; Meyer, J.G.; Dati, F.; Fuhge, P. 1987: Determination of thromboplastin time with a new standardized thromboplastin from human placenta: results of a cooperative study Journal of Clinical Chemistry and Clinical Biochemistry 25(4): 267-280
Van den Besselaar, A.M.; Loeliger, E.A. 1985: Massive hyperanticoagulation following the therapeutic recommendations of a thromboplastin retailer Deutsche Medizinische Wochenschrift 110(23): 937-938
McCarthy, W.H. 2000: Evidence-based management of melanoma. Clinical practice guidelines are now available for managing this cancer which occurs in relatively young people and is a particular problem in Australia Medical Journal of Australia 173(6): 286-287
Barbe, D.; Bauduer, F.; Tanguy, A. 1991: Prothrombin time, activated partial thromboplastin time, plasma fibrinogen determination. Comparison of two automated coagulation systems: Koagulab 40-A and ACL-100 Annales de Biologie Clinique 49(10): 507-513
Zeng, M.; Yi, Q.; Zeng, L.; Chen, Z.; Mi, X.; Song, H.; Zhang, X.; Li, Y.; Wang, Q.; Zhao, R.; Miao, L.; Zhang, L. 2020: Quality of therapeutic drug monitoring guidelines is suboptimal: an evaluation using the Appraisal of Guidelines for Research and Evaluation II instrument Journal of Clinical Epidemiology 120: 47-58
Okamoto, K.; Takeda, S.; Ohsato, K. 1991: Treatment of disseminated intravascular coagulation with proteinase inhibitor Nihon Rinsho. Japanese Journal of Clinical Medicine 49(9): 2130-2135
Joo, K.M.; Song, S.Y.; Park, K.; Kim, M.H.; Jin, J.; Kang, B.G.; Jang, M.J.; Lee, G.S.; Kim, M.S.; Nam, D.-H. 2008: Response of brain specific microenvironment to P-glycoprotein inhibitor: an important factor determining therapeutic effect of P-glycoprotein inhibitor on brain metastatic tumors International Journal of Oncology 33(4): 705-712
Oláh, L.ás.ó; Csépány, T.ün.; Bereczky, Z.; Kerényi, A.; Misz, M.ár.; Kappelmayer, J.án.; Csiba, L.ás.ó 2005: Activity of natural coagulation inhibitor proteins in the acute phase of ischaemic stroke Ideggyogyaszati Szemle 58(1-2): 33-39
Bostwick, J.S.; Bentley, R.; Morgan, S.; Brown, K.; Chu, V.; Ewing, W.R.; Spada, A.P.; Pauls, H.; Perrone, M.H.; Dunwiddie, C.T.; Leadley, R.J. 1999: RPR120844, a novel, specific inhibitor of coagulation factor Xa inhibits venous thrombosis in the rabbit Thrombosis and Haemostasis 81(1): 157-160
Suzuki, S. 1979: Studies on coagulation in newborn infants: liver maturation and vitamin K procoagulant-inhibitor relations Journal of Perinatal Medicine 7(4): 229-232
Gordon, M.; Guralnik, M.; Kaneko, Y.; Mimura, T.; Baker, M.; Lang, W. 1994: A phase i study of curdlan sulfate--an HIV inhibitor. Tolerance, pharmacokinetics and effects on coagulation and on CD4 lymphocytes Journal of Medicine 25(3-4): 163-180
Ohyama, N. 1992: Effect of coagulation inhibitor proteins (Calphobindins) on tissue factor expression of endothelial cells Nihon Sanka Fujinka Gakkai Zasshi 44(9): 1119-1126
Schaeffer, R.C.; Briston, C.; Chilton, S.M.; Carlson, R.W. 1986: Disseminated intravascular coagulation following Echis carinatus venom in dogs: effects of a synthetic thrombin inhibitor Journal of Laboratory and Clinical Medicine 107(6): 488-497
De Clerck, F.; Vermylen, J.; Reneman, R. 1975: Effects of suprofen, an inhibitor of prostaglandin biosynthesis, on platelet function, plasma coagulation and fibrinolysis. I. in vitro experiments Archives Internationales de Pharmacodynamie et de Therapie 216(2): 263-279
Yamazaki, M.; Asakura, H.; Aoshima, K.; Saito, M.; Jokaji, H.; Uotani, C.; Kumabashiri, I.; Morishita, E.; Ikeda, T.; Matsuda, T. 1994: Effects of DX-9065a, an orally active, newly synthesized and specific inhibitor of factor Xa, against experimental disseminated intravascular coagulation in rats Thrombosis and Haemostasis 72(3): 392-396